Why the study?
Does switching to a higher sensitivity troponin assay impact clinical diagnosis and management in patients with suspected ACS?
Observational (n=770)
Does switching to a higher sensitivity troponin assay impact clinical diagnosis and management in patients with suspected ACS?
Switching to a higher sensitivity troponin assay increased the frequency of positive results and NSTEMI admission diagnoses, but paradoxically decreased the use of anticoagulation and cardiac catheterization, with more non-ACS discharge diagnoses.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2014) conducted an observational in Suspected acute coronary syndromes (ACS) (n=770). Contemporary, higher sensitivity troponin assay vs. Previous troponin assay was evaluated on Non-ST segment elevation myocardial infarction at admission (diff -27.5, 95% CI -34.2, -20.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: